BBC Breakfast News discuss the Neupulse trial results - 11.03.2023

Описание к видео BBC Breakfast News discuss the Neupulse trial results - 11.03.2023

Listen to this mornings interview, with our CEO, Emma McNally, who discusses the recent trial results from Neupulse device for suppressing tics in Tourette syndrome.

The trial was run by the University of Nottingham, conducted between 18th March 2022 and 5th of March 2023, sponsored by Nottingham University Hospitals NHS Trust. The aim of the trial was to evaluate the effectiveness of the Neupulse device in reducing the severity and frequency of tics in individuals with Tourette Syndrome. A total of 121 participants took part in the study and went on to receive either active or sham stimulation for 10min a day for 4 weeks.

Комментарии

Информация по комментариям в разработке

Похожие видео